| Date |
|
15 October 2010 |
| Time |
|
7.00am for 7.15am until 8.15am |
| Venue |
|
Foyer Room F1, Brisbane Convention & Exhibition Centre |
| Cost |
|
QCTN Members - AU$22.00 (breakfast event only) |
| |
|
Non-QCTN Members - AU$33.00 (breakfast event only) |
| |
|
A light breakfast will be served from 7.00am and event will finish at 8.15am sharp |
As part of TRX10 week, QCTN is once again pleased to be working with Ernst & Young to offer this special mid-year update presentation of Ernst & Young’s 24th annual biotechnology report – Beyond Borders: The New Normal.
The global biotechnology industry was able to weather the continued worldwide economic turmoil and deliver a strong financial performance in 2009, with the world’s established biotech centres reaching profitability for the first time in history. However, the gap between the haves and have-nots widened, posing new challenges for emerging companies in accessing the capital needed for R&D.
Winna Brown, Ernst & Young’s Australian Life Sciences Leader will share her views on the biggest opportunities for biotech companies operating in the “new normal” as well as the five key guiding principles for companies to follow in these challenging times:
- Seizing funding opportunities
- Boosting capital efficiency
- Focusing on reimbursement
- Collaborating creatively
- Developing differentiating assets.
In Australia, the funding crisis has strained companies and their business strategies and it is expected that this funding drought will continue well into 2011. Please join Winna for an insightful discussion on navigating through the lastest challenges the difficult economic conditions have placed on the biotech industry.
This event will be followed by the CXOForum© incorporating the 5th Australasian Life Sciences Investment Forum - which is separately registrable.
REGISTER NOW!
Thanks to our sponsors: